Is it time to eliminate the need for overnight fasting for lipid tests in patients with diabetes?

JAMA Internal Medicine

Volumn 173, Issue 10, 2013, Pages 936-937

  Aldasouqi, Saleh A ^a   Grunberger, George ^b  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b Grunberger Diabetes Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT;

BLOOD GLUCOSE MONITORING; DIABETES MELLITUS; DIET RESTRICTION; HUMAN; LIPID ANALYSIS; NOTE; PRIORITY JOURNAL;

DYSLIPIDEMIAS; EATING; FASTING; FEMALE; HUMANS; LIPIDS; MALE;

EID: 84878472415     PISSN: 21686106     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamainternmed.2013.398     Document Type: Note

References (5)

1. Sidhu D, Naugler C. Fasting time and lipid levels in a community-based population: a cross-sectional study. Arch Intern Med. 2012;172(22):1707-1710.
2. Aldasouqi S, Sheikh A, Klosterman P, et al. Hypoglycemia in patients with diabetes on antidiabetic medications who fast for laboratory tests. Diabetes Care. 2011;34(5):e52.
3. Grunberger G. Do we need a fasting lipid profile to assess cardiovascular risk? J Diabetes. 2011;3(3):172-173.
4. Gaziano JM. Should we fast before we measure our lipids? Arch Intern Med. 2012;172(22):1705-1706.
5. Khera A, Mora S. Fasting for lipid testing: is it worth the trouble? Arch Intern Med. 2012;172(22):1710-1712.